Table 6.
Parameter | Naive | Placebo | 5% | 10% | 15% |
---|---|---|---|---|---|
Total protein (g/dL) | 6.14 ± 0.51 | 6.33 ± 1.11 | 6.33 ± 0.99 | 6.51 ± 0.97 | 6.61 ± 0.66 |
Albumin (g/dL) | 4.11 ± 0.32 | 3.99 ± 0.66 | 3.92 ± 0.55 | 3.87 ± 0.77 | 4.02 ± 0.44 |
Globulin (g/dL) | 2.33 ± 0.23 | 2.23 ± 0.33 | 2.45 ± 0.40 | 2.37 ± 0.33 | 2.24 ± 0.41 |
AST (U/L) | 126.73 ± 41.23 | 121.66 ± 55.42 | 126.16 ± 56.56 | 120.42 ± 56.65 | 141.23 ± 42.31 |
ALT (U/L) | 55.57 ± 11.20 | 61.12 ± 8.30 | 53.5 ± 9.98 | 52.65 ± 10.56 | 55.77 ± 11.20 |
GGT (U/L) | 1.52 ± 0.54 | 1.47 ± 0.58 | 1.55 ± 0.59 | 1.57 ± 0.61 | 1.61 ± 0.54 |
AP (U/L) | 104.15 ± 55.22 | 112.34 ± 47.49 | 114.10 ± 44.17 | 110.42 ± 51.15 | 109.15 ± 49.29 |
TB (mg/dL) | 0.047 ± 0.017 | 0.046 ± 0.017 | 0.048 ± 0.019 | 0.049 ± 0.020 | 0.047 ± 0.017 |
TG (mg/dL) | 77.12 ± 7.01 | 71.22 ± 8.12 | 70.77 ± 8.21 | 68.99 ± 9.99 | 68.19 ± 8.89 |
TC (mg/dL) | 60.17 ± 11.02 | 61.57 ± 10.04 | 67 ± 8.02 | 66.15 ± 8.19 | 69.17 ± 10.22 |
HDL-C (mg/dL) | 28.22 ± 6.14 | 30.29 ± 7.11 | 35.66 ± 9.99 | 32.77 ± 7.54 | 27.55 ± 5.55 |
VLDL-C (mg/dL) | 13.12 ± 3.12 | 12.11 ± 3.01 | 12.14 ± 2.99 | 13.09 ± 3.99 | 14.82 ± 4.22 |
LDL-C (mg/dL) | 21.11 ± 3.23 | 25.33 ± 4.11 | 24.13 ± 5.02 | 23.11 ± 4.99 | 20.92 ± 4.12 |
Creatinine (mg/dL) | 0.33 ± 0.08 | 0.35 ± 0.09 | 0.39 ± 0.07 | 0.37 ± 0.08 | 0.36 ± 0.09 |
Urea (mg/dL) | 50.01 ± 8.31 | 48.12 ± 6.99 | 49.22 ± 8.43 | 50.07 ± 9.31 | 52.66 ± 9.66 |
Progesterone (pg/mL) | 28.06 ± 7.34 | 30.11 ± 6.16 | 30.22 ± 8.11 | 33.07 ± 9.31 | 28.21 ± 8.31 |
Estradiol (pg/mL) | 47.22 ± 11.23 | 54.55 ± 12.21 | 52.01 ± 10.99 | 48.98 ± 8.99 | 45.22 ± 11.21 |
Free T3 (ng/mL) | 0.52 ± 0.11 | 0.55 ± 0.10 | 0.52 ± 0.10 | 0.52 ± 0.10 | 0.53 ± 0.11 |
TSH (ng/mL) | 4.71 ± 0.70 | 5.02 ± 0.72 | 4.93 ± 0.77 | 5.01 ± 0.89 | 4.98 ± 0.88 |
Statistical analyses were performed using one–way ANOVA followed by Bonferroni’s post-hoc test. Values are expressed as mean ± SEM (standard error of the mean). n = seven rats per group.